StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Amphastar Pharmaceuticals (AMPH) PT Raised to $17 at BMO Capital on 3Q Report; 'Awaiting Execution With Key Pipeline Opportunities'
November 10, 2017 9:29 AM
BMO Capital raised its price target on Amphastar Pharmaceuticals (NASDAQ: AMPH) to $17.00 (from ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS Change
Analyst EPS View
Analyst PT Change
Next Articles
Amphastar Pharmaceuticals (AMPH) PT Raised to $23 at Jefferies
November 9, 2017 8:28 AM
Amphastar Pharmaceuticals (AMPH) PT Raised to $23 at Piper Jaffray
November 9, 2017 7:52 AM
Raymond James Downgrades Amphastar Pharmaceuticals (AMPH) to Market Perform
November 9, 2017 4:40 AM
Amphastar Pharma (AMPH) Tops Q3 EPS by 5c
November 8, 2017 4:08 PM
